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The tandem-repeat Galectin-4 (Gal-4) contains two different domains covalently linked
through a short flexible peptide. Both domains have been shown to bind preferentially to
A and B histo blood group antigens with different affinities, although the binding details
are not yet available. The biological relevance of these associations is unknown, although
it could be related to its attributed role in pathogen recognition. The presentation of A and
B histo blood group antigens in terms of peripheral core structures differs among tissues
and from that of the antigen-mimicking structures produced by pathogens. Herein, the
binding of the N-terminal domain of Gal-4 toward a group of differently presented A and
B oligosaccharide antigens in solution has been studied through a combination of NMR,
isothermal titration calorimetry (ITC), and molecular modeling. The data presented in this
paper allow the identification of the specific effects that subtle chemical modifications
within this antigenic family have in the binding to the N-terminal domain of Gal-4 in terms
of affinity and intermolecular interactions, providing a structural-based rationale for the
observed trend in the binding preferences.
Keywords: NMR, molecular recognition, galectin-4, blood type antigen, lectin—carbohydrate interaction
INTRODUCTION
Galectin-4 (Gal-4) is one of the 16 members of the human galectin family, characterized by their
participation in a myriad of biological phenomena, with important implications in immunity (Sato
et al., 2009; Giovannone et al., 2018; Martínez Allo et al., 2018), inflammation, and cancer (Elola
et al., 2018). They exert their functions through their ability to bind β-galactoside-containing
glycans, toward which the different galectins present different affinities and selectivities.
The physiological roles of Gal-4 have been reviewed (Cao and Guo, 2016) and include apical
protein trafficking, intestinal wound healing, lipid raft stabilization, and bacterial pathogen fighting.
In healthy individuals, Gal-4 is predominantly expressed in the epithelial cells along the alimentary
tract; although, similar to other members of the galectin family, its distribution in cancer is altered
(Huflejt and Leffler, 2003). Although its exact roles in the disease are not fully understood, the
correlation between Gal-4 levels and malignancy has been reported for many types of cancer (Tsai
et al., 2016). These pieces of evidence have in fact fostered the use of Galectins as targets for
therapeutic intervention for several types of cancer (Cagnoni et al., 2016; Girard and Magnani,
2018).
Quintana et al. Galectin-4 and Blood Type Antigens
Galectin-4 belongs to the tandem-repeat galectins subfamily,
characterized by displaying two different carbohydrate
recognition domains (CRDs) covalently linked through a
short peptide. The role of this peptide linker in the overall
protein behavior is not yet clear, neither is its influence on
the carbohydrate-binding properties. In the case of Gal-4, the
two CRDs show a 49% similarity and, despite sharing certain
glycan-binding preferences, they do not completely overlap.
Previous studies on the binding preferences of the full-length
form of Gal-4 (Ideo et al., 2002, 2005; Vokhmyanina et al., 2012)
as well as on the two independent N- and C-terminal domains
(Huflejt and Leffler, 2003) have revealed their preference toward
the human histo blood group antigens (HBGAs) A and B.
Despite certain controversy (Vokhmyanina et al., 2012), most
studies agree on the fact that the N-terminal domain of Gal-4
(Gal-4N) recognizes A and B blood group antigens with less
affinity than the C-terminal domain (Gal-4C). Nevertheless,
significant discrepancies on the binding affinities were reported
(Ideo et al., 2005, 2011; Bum-Erdene et al., 2016). X-ray
crystallography analysis has provided structural details on how
the two independent CRDs recognize different linear lactose
derivatives, including 2′-fucosyl lactose (H type-6 antigen)
SCHEME 1 | (A) The A and B histo blood group antigens and their possible peripheral disaccharide core structures (the core types studied herein are in bold). X
stands for the linked atom at the reducing-end residue (X = 3 for types-1 and -4; X = 4 for types-2 and -6). (B) Tetra- and pentasaccharide representative structures
of the A and B blood group antigens of type-1, -2, -4, and -6 studied herein. The difference between A and B antigens is the substituent at C2 of the terminal residue
(highlighted in blue): -OH (Gal) for the B antigen, and NHAc (GalNAc) for the A antigen. The type depends on the peripheral disaccharide core structure whose
structural differences are highlighted in orange.
(Bum-Erdene et al., 2015, 2016). However, no experimental
data are yet available for the recognition of branched antigens,
including the blood-type antigens.
In particular, the ABO antigens are divided into six
groups, depending on their peripheral core disaccharide
structures (Scheme 1), namely type-1 (Galβ1-3GlcNAcβ), type-
2 (Galβ1-4GlcNAcβ), type-3 (Galβ1-3GalNAcβ), type-4 (Galβ1-
3GalNAcβ), type-5 (Galβ1-3Glcβ), and type-6 (Galβ1-4Glcβ),
giving rise to a family of epitopes which are presented in different
manners. This different presentation is known to influence
their antigenicity (Watkins et al., 1988; Clausen and Hakomori,
1989; Tanaka et al., 2008). Moreover, their distribution is also
different. HBGAs are mostly present as type-2 structures (N-
acetyl lactosamine, Galβ1-4GlcNAcβ). However, HBGAs are not
only found on red blood cells but also on the cell surfaces of
most endothelial and epithelial cells and in the secretions of
the so-called AB-secretor genotype individuals. In fact, type-1
antigens are found on endodermal tissues and type-2 antigens are
found on both ecto- and endo-dermal tissues, while type-3 and-
4 antigens are present on ecto- or endodermally derived tissues,
including the salivary glands and kidneys. While the presence
of type-5 antigens in humans is controversial (Meloncelli and
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Lowary, 2010), type-6 antigens have been much less studied and
they have been reported to be in human milk and tissue samples
(Breimer et al., 1982).
From a biological perspective, the significance of the specific
association of HBGAs with certain members of the galectin
family seems intriguing. It has been suggested (Kamili et al.,
2016) that some galectins could fill an important gap in
adaptive immunity by conferring protection against pathogens
that use molecular mimicry for the infection, producing blood
group-like antigenic glycan structures (Arthur et al., 2015).
Thus, individuals of a given blood type, who do not produce
antibodies against their own blood group antigens, would then
be protected by the immune activity of galectins. In support of
this hypothesis, Gal-4 was demonstrated to be able to recognize
and kill Escherichia coli bacteria expressing the blood group B
antigen (Stowell et al., 2010). Interestingly, a quick glance at
the O-antigenic structures produced by E. Coli (Stenutz et al.,
2006) reveals that not only the O86 E. Coli serotype (that
precisely express the B-antigen structure) but also other serotypes
incorporate O-antigens that share common structural elements
with galectin ligands. Their chemical context compared to the
endogenous epitopes is however different, for instance, with
respect to their neighboring residues and linkages. Considering
the diversity of the ABO antigen presentation in terms of
peripheral glycan structures (types), among both endogenous
glycans and host-mimicking pathogenic glycans, the influence
of this presentation on their recognition by Gal-4N has been
explored here.
A library of commercially available HBGAs with different
presentations at the peripheral disaccharide core (Scheme 1)
was selected to interrogate the binding preferences of Gal-
4N toward the possible chemical variations within this glycan
antigenic family. In particular, this study has focused on the
A vs. B preference and on the chemical variations involving
their peripheral core presentation, including the glycosidic
linkage (β1–3 vs. β1–4) as well as the nature of the first
peripheral core monosaccharide (GlcNAc, GalNAc, or Glc). This
paper presents a systematic study based on experimental NMR
data and isothermal titration calorimetry (ITC) measurements,
which, combined with computational chemistry tools, provide an
atomic-level rationalization of the observed binding preferences
of Gal-4N.
RESULTS AND DISCUSSION
The interaction of Gal-4N with the A and B type-1, -2,
and -6 tetrasaccharides and their interaction with the A
and B type-4 pentasaccharides (Scheme 1) were addressed
by combining different NMR-based strategies. 1H-Saturation
Transfer Difference (STD) NMR experiments were employed
to report on the glycan binding epitope (Bhunia et al., 2012;
Wagstaff et al., 2013; Marchetti et al., 2016). Additionally, ROESY
experiments of ligand/Gal-4N mixtures revealed specific ligand
1H resonances in slow exchange in the NMR chemical shift
timescale between the free and bound states. Fittingly, the
analysis of their chemical shift differences (1δ1H free-bound)
proved to be instrumental in providing a sort of information
on ligand binding epitope complementary to that obtained by
using the STD experiments. Additionally, experiments from
the protein perspective, based on the observation of 15N-
labeled Gal-4N, were used to estimate binding constant affinities
(KD) and to determine the binding epitope of the lectin in
each case, which were further quantitatively measured by ITC.
The synergic combination of these experimental data with
molecular modeling procedures provided detailed 3D models of
the complexes.
NMR
1H-Saturation Transfer Difference NMR
1H-saturation transfer difference NMR spectra were acquired for
mixtures of Gal-4N (50µM) with a 50-fold excess of ligand.
Protein aromatic irradiation afforded the best STD intensities
and thus these are discussed henceforth. The STD NMR spectra
were very similar among the different ligands with respect to
both the observed glycan protons and their intensities. For all
the ligands, all the protons of the central βGal residue except
H2, together with H1 and H2 of the terminal αGal/αGalNAc
residues, showed the strongest relative STD NMR effects (above
50%) as shown in Figure 1 and Supplementary Information.
Severe proton overlapping precluded a full comparison among
ligands, but key isolated 1HNMR resonance signals permitted to
highlight evident differences.
In particular, the comparison of the 1H-STD NMR signals
originating from the acetyl groups was highly informative. For all
the A-type antigens, the Ac group at the terminal GalNAc residue
showed very strong STD intensity (Figure 1B). In contrast, the
Ac groups at the reducing-end GlcNAc, present in type-1 (β1–
3) and type-2 (β1–4) antigens, displayed weaker intensities.
However, these signals were always stronger for the β1–3 than
for the alternative β1–4 linked antigens (Figure 1B). This fact
indicates that this NAc group is closer to protein aromatic
residues (the STD on-resonance frequency irradiation) for the
β1–3 linked epitopes than for the analogous NAc for β1–
4 presentations.
The methyl group of the Fuc moieties showed weak
STD intensities, always below 20%. Interestingly, they were
systematically much weaker for the A antigens than for the B
antigens (see Supplementary Information). These data clearly
indicate that the Fuc residue is further away from the protein
surface in the lectin complexes with the A antigens than in those
with the B analogs.
For the longer pentasaccharides A and B type-4 antigens,
there was a remarkable lack of STD effect at the reducing-
end Gal residue (Figure 2) and very weak for the βGalNAc,
clearly indicating that the binding epitope implies exclusively the
terminal residues. This is a fairly interesting observation since the
type-4 core structure (Scheme 1) contains the GalNAcβ1-3Gal
moiety at the reducing end that could act as an additional binding
epitope by positioning the GalNAcβ- residue on the primary
binding site (stacked on W84), increasing the apparent binding
affinity. These data strongly suggest, however, that this is not
the case.
Transverse ROESY NMR
Transverse ROESY (trROESY) spectra were acquired in
1:20 protein/ligand molar ratios (Asensio et al., 1995). The
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FIGURE 1 | (A) 1H STD NMR experiment for the complex formed by the A type-6 tetrasaccharide and Gal-4N (50:1 molar ratio). Top: the reference spectrum (black,
off-resonance). Bottom: the STD NMR spectrum (green, on-resonance at the aromatic region). The 1H-NMR signals showing STD effect are annotated. The epitope
mapping (relative STD) is shown in the ligand structure. (B) Details of the off-resonance and the STD NMR spectra showing the NAc region obtained for the HBGAs in
the presence of Gal-4N: from left to right: A type-6, B-type-1, B-type-2, and B-type-4. Terminal refers to the terminal α-GalNAc residue. Red-end refers to the
reducing-end GlcNAc or GalNAc residues. The intensities of the STD spectra are 75-fold incremented with respect to the reference off-resonance spectra.
FIGURE 2 | 1H STD NMR experiment for the complex formed by the B type-4 pentasaccharide and Gal-4N (50:1 molar ratio). Top: the reference spectrum (black,
off-resonance). Bottom: the STD NMR spectrum (green, on-resonance at the aromatic region). The 1H-NMR signals showing STD effect are annotated. The epitope
mapping (relative STD) is shown in the ligand structure. *overlapping proton signals.
comparison of the observed ROESY cross-peaks with those
recorded for the free ligands was very similar, indicating that no
significant conformational changes around the glycosidic torsion
angles or at the pyranose chairs took place upon binding. Most
interestingly, these trROESY spectra evidenced that some ligand
protons were in slow chemical exchange between their free
and bound states (Figure 3), thus revealing the corresponding
chemical shifts in the bound states (Gimeno et al., 2019).
Fittingly, those signals experiencing slow exchange in the NMR
chemical shift timescale are expected to arise from protons that
significantly change their chemical environment upon complex
formation and that are highly affected by their proximity to
the lectin surface. Remarkably, not all ligand protons showed
chemical exchange cross-peaks. The analysis of the chemical shift
difference between the free and bound forms [1δ (free−bound)]
thus afforded additional epitope mapping information from the
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FIGURE 3 | 1H-NMR-based ligand chemical exchange (EXSY) analysis from the trROESY experiments. (A) trROESY spectrum of the B type-6 tetrasaccharide
antigen in the presence of Gal-4N (molar ratio 20:1). The cross-peaks in black correspond to those arising from regular nuclear Overhauser effects in the rotating
frame, while those in red arise from chemical exchange. Their chemical shifts at the different 1H dimensions in the 2D spectrum correspond to those in the free
(down-field) and bound (up-field) states. (B) Plot for the measured differences in chemical shifts between the free and bound states (1δ[1H] free-bound) for those
selected protons of the antigens that experience slow exchange in the ROESY spectrum in the presence of the lectin.
ligand perspective. Moreover, the comparison of the behavior
observed for the different ligands also permitted the deduction
of subtle differences related to their different binding geometries
into the galectin binding site. Notably, for all ligands, all the
protons of the central βGal residue experienced drastic up-
field shifts upon complex formation, with H4, H5, and one
of the H6 standing out with more than δ 2 ppm difference
between the free and bound forms (Figure 3). This effect
is in full agreement with the expected key CH-π stacking
interaction (Asensio et al., 2013) between the central βGal
residue and the indole side chain of W84 of the lectin. This
key βGal/Trp interaction is ubiquitous for all galectins (Dings
et al., 2018; Bertuzzi et al., 2020). Nevertheless, the profile is
slightly but noticeably different for the A and the B antigens
(Figure 3). For the B epitopes, H1 and H2 of the terminal
βGal moiety experienced slow exchange, being up-field shifted
upon binding. On the contrary, for the A-antigens, only H1
of the analogous βGalNAc residue displayed slow exchange
with a reduced chemical shift perturbation, while H2 was not
in slow exchange. The chemical shift difference free-bound for
H4, H5, and H6′ of the central βGal was also smaller for the
A antigens than for the B antigens (Figure 3), suggesting that
the stacking interaction is stronger for the latter. Additionally,
H1-Fuc (the only proton of the Fuc ring under slow exchange)
is more affected in the B antigens [1δ(free−bound) = 0.2–0.3
ppm] than in the A antigens (<0.2 ppm). These differences
strongly suggest that the A and B antigens display a slightly
different orientation in the Gal-4N binding site. Additionally,
very few protons at the reducing-end residues showed weak
chemical exchange effects (see Supplementary Information).
Finally, the type-4 oligosaccharides did not show any chemical
exchange effect.
Chemical Shift Perturbations at Gal-4N
The molecular recognition event was also analyzed from the
perspective of the lectin. Thus, a chemical shift perturbation
(CSP) analysis of the changes produced in the 1H-15N HSQC
spectra recorded for 15N-labeled Gal-4N upon addition of
the different ligands was carried out. This analysis required
the NH backbone NMR assignment of the lectin signals,
following well-established triple resonance 3D NMR methods
(see Materials and methods and Supplementary Information).
The assignment protocol allowed assigning 80% of the NH
backbone resonances. In addition to the ligands shown in
Scheme 1, the corresponding non-fucosylated analogs and the
H antigens (devoid of the terminal Gal/GalNAc moieties,
see Supplementary Information), as well as lactose, were
also employed. Thus, a full comparative analysis on the
monosaccharide-specific effects on the lectin CSP was achieved.
In addition, titration experiments afforded an estimation of the
binding affinities, which are provided in Table 1.
The observed CSP for the interaction with the trisaccharide
2’-fucosyllactose (H type-6) was the same as that for lactose,
suggesting that the Fuc residue does not provide direct
interactions with the lectin. In contrast, when the non-
fucosylated B type-6 antigen was employed, additional CSPs with
respect to lactose were observed. These perturbations took place
mainly at the S2 strand and at the side chain of W84, evidencing
that the terminal αGal unit indeed interacts with this area of
Gal-4N (Supplementary Information).
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TABLE 1 | Equilibrium dissociation constants (KD) determined for the interactions of the different A and B blood group antigens with Gal-4N by employing HSQC
NMR-based titrations and ITC measurements, along with the thermodynamic parameters for the interactions, as determined by ITC.
Ligand KD (µM) KD (µM) 1G (kcal mol
–1) 1H (kcal mol–1) -T1S (kcal mol–1)
(NMR) (ITC) (ITC) (ITC) (ITC)
A type-1 (tetra) 440 267 −4.9 −5.9 1.0
A type−2 (tetra) 370 187 −5.1 −6.9 1.8
A type-4 (penta) 1,380 - - - -
A type-6 (tetra) 150 86 −5.6 −8.5 2.9
B type-1 (tetra) 200 109 −5.4 −7.7 2.3
B type-2 (tetra) 190 88 −5.5 −9.3 3.8
B type-4 (penta) 460 - - - -
B type-6 (tetra) 60 51 −5.9 −12.3 6.4
The CSP measured for the A antigens vs. the B antigens
showed significant differences for several residues, all located
along the S face of Gal-4N (Figure 4). Some of these residues
cluster in the S2 strand, such as V138, D139, and G140. These
residues are remarkably differently affected by the A and B
antigens, both inmagnitude and direction: they aremore strongly
perturbed in the presence of A antigens, moving up-field in the
1H dimension, than in the presence of B antigens (Figure 4C).
The analysis of the published x-ray crystallographic structures
(Bum-Erdene et al., 2015) showed that these amino acid residues
are facing F47, located at the contiguous S3 strand. The observed
trends suggest that the interaction with the A-antigens moves
residue F47 closer to these V138-G140 residues, a motion that
does not take place when the B-antigens are bound (Figure 4A).
The different blood group types also displayed distinct CSP
of the lectin cross-peaks. The CSP between types-1 and -2
were basically identical, with only subtle differences at V75
(S5) and R89 (S6) (Supplementary Information), while type-
6 oligosaccharides presented different perturbations all along
the S5 and S6 strands (Supplementary Information) with the
strongest differences involving residues E87, R89, and K90. As for
the type-4 antigens, there was a remarkable lack of perturbations
at the S5 strand (Figure 5), more pronounced for the B antigen
than for the A antigen (Supplementary Information).
In addition to the information yielded by the CSP analysis,
titrations provided an estimation of the equilibrium dissociation
constants of each ligand (KD, Table 1). The NMR-based binding
affinities spanned a 20-fold range between the best (B-type 6) and
worse (A-type 4) binders, with KD values in theµM tomM range.
Lactose, the minimum binding epitope, also exhibited a very
low, although measurable, affinity with a KD of 1.6mM, which is
in agreement with previously reported data (Bum-Erdene et al.,
2016; Sindrewicz et al., 2019). Interestingly, the tetrasaccharides
presented conserved trends in their binding preferences. Thus,
for the same peripheral core structure, the B-type antigens were
always better binders than the corresponding A-type antigens.
With respect to the core structures, type-6 are the best binders,
followed by types-1 and -2 that are very similar, irrespective of
their terminal residues (whether they are A or B). Finally, the
type-4 oligosaccharides were the worse binders, with A type-4
being almost as weak as lactose.
Isothermal Titration Calorimetry
In order to provide alternative and complementary estimations
of the binding affinity data, ITC experiments were also
carried out for the six HBGA tetrasaccharides (Table 1).
The binding with the type-4 pentasaccharides was too weak
to obtain reliable ITC data. The thermodynamic profile
for all the interactions showed the typical enthalpy-driven
binding process (Table 1). The best enthalpy values are always
compensated by opposing entropy contributions, especially
significant for the B-type 6 oligosaccharide. The significant
favorable binding enthalpy (−12.3 kcal/mol) is accompanied
by the largest entropy penalty (−6.4 kcal/mol). This binding
profile constitutes a prototypical example of enthalpy-entropy
compensation with a nearly perfect relationship between 1H
and –T1S (see Supporting Information). However, due to
the moderate- or low-affinity interactions (all with KD values
above 50µM), the resulting thermodynamic parameters will
not be further interpreted (Turnbull and Daranas, 2003).
Although the magnitudes of the ITC-derived KD values were
on average 1.5-fold lower than those determined by NMR, both
techniques yielded conserved trends, reproducing the binding
preferences described above; this process is schematized in
Figure 6.
The trend is very clear: The B group antigens are
better binders than their corresponding A group analogs.
Regarding the peripheral disaccharide cores, the type-6 antigens
are preferentially recognized, while the type-4 ones display
very weak affinity. The type-1 and type-2 antigens display
intermediate affinities.
In particular, for β1–4 linked antigens, the substitution of Glc
by GlcNAc at the reducing-end is detrimental for the binding
event, as evidenced by the comparison between A type-2 and
A type-6 and between B type-2 and B type-6. In both cases, a
two-fold increased affinity is observed for the type-6 linkages.
In contrast, the presentation of the β1-3GlcNAc vs. β1-
4GlcNAc epitopes at the peripheral core (type-1 vs. type-2)
basically does not influence the binding affinity for both the A
and the B tetrasaccharides.
Finally, the B antigens (with a terminal αGal residue) always
bind 2-fold stronger than the A antigens (with a αGalNAc
residue), irrespective of the peripheral core disaccharide.
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FIGURE 4 | Protein backbone CSP analysis for the interaction of Gal-4N with A and B type-6 tetrasaccharide antigens. (A) Molecular model (MD simulation) for the
complex of Gal-4N with A type-6 antigen. The residues that significantly differ in their chemical shift perturbation upon binding to group A or B antigens are highlighted
in orange, as well as F47 (unknown resonance assignment). Left: zoom at the S2–S3 region showing residues F46, V138, D139, and G140. (B) Superimposition of
the 1H-15N HSQC spectra of Gal-4N in the presence of A type-6 (blue) and B type-6 antigens (red). (C) Expansion of the 1H-15N HSQC spectra at residues V138,
D139, and G140: in green, Gal-4N apo; in blue, Gal-4N/A type-6 (12 eq.); and in red Gal-4N/B type-6 (10 eq.).
FIGURE 5 | 1H-15N HSQC: chemical shift perturbation of residues V75 and F76 of Gal-4N in the presence of the B antigens types-1, -2, -4, and -6.
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FIGURE 6 | Schematic representation of the affinity trends for the binding of the A and B blood group antigen tetrasaccharides (types-1, -2, and -6) to Gal-4N as
deduced by ITC. The NMR-based data follow the same trend although the estimated binding affinities are ca. 1.5-fold weaker. The type-4 oligosaccharides are not
displayed since their affinities are even weaker than those of the type-1 analogs.
The binding preferences of Gal-4N can be thus be categorized
as shown in Figure 6, where the B type-6 is the best binder
with a 5-fold difference in affinity. Therefore, Gal-4N prefers
αGal moieties at the non-reducing end and Glc residues at the
reducing end.
Three-Dimensional Structural Models for
the Binding Complexes
Once the experimental data were available, 3D structural
models for the complexes were generated by atom-pair
superimposition of the central βGal pyranose of the ligands
with the corresponding residue in the x-ray crystallographic
structure of the reported complex of Gal-4N bound to lactose
(pdb 5DUV) (Bum-Erdene et al., 2015). Then, the generated
complexes were submitted to 1 µs molecular dynamics (MD)
simulations using the ff14SB and GLYCAM06j-1 force fields as
implemented in Amber18. Figure 7 gathers the superimposition
of the complexes formed by Gal4-N with the A type-6 and the
B type-6 antigens as a summary of the results. Fittingly, the
subtle different orientations and presentations of the ligands at
the lectin binding site permit the explanation of the observed
differences found in the combined ligand-based and receptor-
based NMR analysis and the ITC measurements.
As discussed above, the B antigens are better binders (and
display better enthalpies) than the A analogs. In fact, according
to the MD simulations, only in the A-complex, the bulky Ac
group at the terminal GalNAc pushes F47 (in S3) away, moving
it toward S2. The lack of this Ac group in the B-complex allows
for a better binding. These theoretical predictions are in full
agreement with the experimental observations found in the CSP
analysis (Figure 3). In fact, for all the A antigens, the αGalNAc
residue is further away from the protein surface. For instance,
for the group A type-6, H2-αGalNAc is on average at 5.3 Å from
the aromatic ring of F47, whereas for the group B type-6, H2-
αGal is only 3.5 Å away from the aromatic ring of F47. This
fact perfectly matches with the chemical exchange observations
in the trROESY experiments in which this proton is up-field
shifted only for the B antigens. The ring current effect of the
F47 aromatic ring affects H2-αGal due to its close proximity and
orientation (Figure 7). Regarding the central βGal moiety, given
the diverse presentation and fitting of the terminal residues, this
βGal residue in the A and B antigens is also differently positioned
with respect to the amino acids that comprise the binding site
(Figure 7). In fact, in the A antigens, H4-βGal is 0.5 Å further
away from the imidazole ring of H63 than in the B antigens.
Additionally, H5-βGal is also 0.4 Å further away from the indole
ring of W84 in the A antigens than in the B antigens. These
different geometries also correlate with the observed stronger
chemical shift perturbations of these protons in the B antigens
than in A antigens. These geometric differences also impact both
the strength of the βGal/W84 CH-π interaction as well as the
OH4-βGal/H63 hydrogen bond, which are key interactions in the
molecular recognition of βGal moieties by galectins.
With respect to the core-disaccharides, the MD simulations
show that, in the β1–4 linked epitopes (types-2 and -6), positions
2 and 3 of the reducing-end pyranose ring are facing the
lectin, while in β1-3 linked analogs (types-1 and -4), these
positions are in the opposite direction, exposed to the bulk
solvent (Figure 8). These MD-based orientations are also in
full agreement with the STD data discussed above. For the β1-
4 linked epitopes, the MD simulations also predict hydrogen-
bonding interactions between OH3 of the reducing end sugar
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FIGURE 7 | Different perspectives of the superimposition of the 3D models for the complexes Gal-4N/A type-6 (orange) and Gal-4N/B type-6 (green) according to the
MD simulations. Reducing-end and Fuc residues are faded. Key residues of the protein are highlighted.
FIGURE 8 | Molecular models of the complexes between Gal-4N and group B types-1, -2, -4, and -6 antigens according to MD simulations. Key residues are
highlighted.
(Glc/GlcNAc) and the polar side chains of R65 and E87. Also,
only in the type-6 antigens, an additional hydrogen bond is
established between OH2-Glc and the carboxylate group of
E87. This additional stabilizing interaction could provide the
impetus for the additional affinity gain observed in the type-6
vs. the type-2 cores. In type-1 antigens, which are β1-3 linked,
R65 and E87 establish hydrogen bonding with OH4-GlcNAc.
Thus, despite the different orientations of the reducing-end
pyranose with respect to β1-4 linked antigens, type-1 and type-
2 would be balanced in terms of establishing interactions, which
is in agreement with their similar affinities. Finally, for type-4
antigens, the axial disposition of the OH4-GalNAcβ precludes the
interactions with R65 and E87, which is in agreement with their
reduced affinity.
CONCLUSIONS
Herein, the binding preferences of the N-terminal of Gal-4
toward A and B blood group antigens have been examined at
the molecular level. Different antigenic presentations in terms
of peripheral core structures have been compared, as well as
the A vs. B antigen preference. The ITC experiments permitted
the classification of the ligands in terms of binding affinity,
while different NMR strategies in combination with modeling
protocols provided the structural rationale for the observed
binding preferences. All the ligands bound Gal-4N with similar
affinities, with KD values in the range of 10−5−10−4 M for
the tetrasaccharides and a 7-fold difference between the best
and worse ligands, while the pentasaccharides bound weaker by
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one order of magnitude (KD values in the range of 10−4−10−3
M). Conserved binding trends were observed. For the same
peripheral core structure, the B antigen was always a better binder
than the A antigen, indicating that the NAc group on the terminal
αGal residue is detrimental for the binding. A similar effect was
found for β1-4 linked antigens at the peripheral core, for which
the presence of the NAc in type-2 antigens (β1-4GlcNAc) was
again detrimental for the binding with respect to type-6 antigens
(β1-4Glc). The type-1 and type-2 antigens, despite the different
orientation of their reducing-end residues with respect to the
protein, displayed similar affinities.
The experimental NMR observations, both from the ligand
and lectin perspectives, could be nicely reconciled with the
molecular models for the complexes obtained through MD
simulations, where the slightly different chemical modifications
among the ligands provoked subtle structural differences in the
complexes, with diverse impacts in the binding affinities. These
data might help in understanding the binding preferences of Gal-
4 toward the histo blood group antigens, especially with respect
to their different presentations in distinct biological contexts
(e.g., tissues) or their diverse origins (self vs. pathogenic). In
addition, this study provides detailed atomic-level information
and dynamic features about Gal-4N binding characteristics,
which are relevant in the context of rational ligand design.
MATERIALS AND METHODS
Ligands
Lactose was purchased from Sigma (St. Louis, MO,
United States). Glycans H type-6, B type-6 trisaccharide, A
types-1, -2, and -6 tetrasaccharides, A type-4 pentasaccharide, B
types-1, -2, and -6 tetrasaccharides, and B type-4 pentasaccharide
were purchased from Elicityl (Crolles, France) (references
GLY031-3, GLY074-2, GLY035-1, GLY035-2, GLY035-3,
GLY128, GLY038-1, GLY038-2, GLY038-3, GLY129).
Protein Expression and Purification of
Gal-4N
The DNA fragment coding for the N-terminal CRD of hGalectin-
4 (amino acids 1–150, including an additional C-terminus His-
Tag) was inserted into the pET29b expression vector, amplified
in E. coliDH5α cells, and afterward transformed into E. coli BL21
cells. A single colony was inoculated into 200ml Luria Broth (LB)
medium containing 50 µg ml−1 kanamycin and was cultured at
37◦C overnight. A precise quantity of the cultured colony was
then added to 2 L of fresh LB containing kanamycin to achieve
an initial optical density at 600 nm (OD600) of 0.1. The cells were
grown at 37◦C until the OD600 reached 0.6–0.8; subsequently,
protein expression was induced by addition of 1mM of
isopropyl-1-thio-β-D-galactopyranoside (IPTG), and the culture
was allowed to grow overnight at 20◦C. For the 15N-labeled and
13C,15N-labeled samples, a single colony was inoculated into 5ml
of LB and was cultured for 6 h at 37◦C. The small preculture was
centrifuged and resuspended in 1ml of M9 medium, transferred
to 200ml of M9 medium, and then incubated overnight at 37◦C.
A precise quantity of the culture was then added to 2 L of
fresh M9 medium containing 1 g/L 15NH4Cl for the 15N-labeled
samples, or 1 g/L 15NH4Cl and 20% w/v U–13C-glucose for the
13C,15N-labeled samples. Unlabeled amino acids (L-Arginine, L-
Phenylalanine, L-Valine, or L-Lysine) were added in the quantity
of 1 g/L to the M9 medium containing 1 g/L 15NH4Cl to
selectively not label concrete amino acids of the protein. The
culture was harvested by centrifugation at 5,000 rpm and the
final pellet was resuspended in lysis buffer (50mM sodium
phosphate, pH 8, 300mM NaCl, 1mM phenylmethylsulfonyl
fluoride) and sonicated at 4◦C. The crude extract was clarified
by centrifugation at 35,000 rpm for 1 h at 4◦C. The soluble
fraction was purified by Ni-NTA (Sigma, St. Louis, MO, United
States) affinity chromatography and further purified by size
exclusion chromatography in a HiLoad 26/600 Superdex 75
column (Sigma, St. Louis, MO, United States). The C-terminal
His-Tag was removed by overnight incubation at 4◦C with
thrombin (10 units of thrombin per mg of protein). Afterward,
the protein was loaded onto a 5ml Ni-NTA column, and the
desired fragment was collected in the wash and loaded in a
HiLoad 26/600 Superdex 75 column. Gal-4N purity was checked
by 4–12% SDS-PAGE (Thermo Fischer, Waltham, MA, United
States) and by LC-MS.
NMR Experiments. General Information
The total volume for the NMR samples was 500/µl. The lectin
was in phosphate-buffered saline (50mM sodium phosphate,
150mM NaCl, pH 7.4), either in D2O or 90:10 H2O:D2O
depending on the NMR experiment. The pH was adjusted with
the required amount of NaOH and HCl or NaOD and DCl.
Backbone Resonance Assignment
The backbone resonance assignment of the N-terminal CRD
of hGalectin-4 was performed at 25◦C on an 800 MHz Bruker
spectrometer equipped with a cryoprobe (Bruker, Billerica, MA,
United States). 3D HNCO, HN(CA)CO, HN(CO)CACB, and
HNCACB experiments were performed and assigned for the free
Gal-4N containing the His-Tag and for Gal-4N without the His-
Tag in the presence of 200 equivalents of lactose. Additionally,
HN(CO)CA and HNCA experiments were recorded for the free
protein containing the His-Tag. The entire analysis provided the
unambiguous identification of 80% of the expected NH signals
for Gal-4N. The spectra were processed with Bruker TopSpin
3.5.2 (Bruker, Billerica, MA, United States) and analyzed via
CARA NMR 1.9.1.4.
Saturation Transfer Difference NMR
All the STD NMR experiments were performed using an
800 MHz Bruker spectrometer with a cryoprobe (Bruker,
Billerica, MA, United States). The samples were prepared in the
corresponding deuterated buffer. The temperature was 288K for
every experiment. An amount of 50µM of the lectin with 50
equivalents of the ligand was employed for every experiment
except for lactose, for which a 1:70 ratio was used. The STD
spectra were acquired with 1,024 scans, 2 s of saturation time
using a train of 50ms Gaussian-shaped pulses, and 3 s of
relaxation delay. The spin-lock filter applied to remove the signals
of the lectin was set at 40ms. The on-resonance frequency was
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set for the aromatic region at 6.58 ppm, while the off-resonance
frequency was set at 100 ppm.
1H-15N-HSQC-Based Titrations
experiments were acquired using an 800 MHz Bruker
spectrometer with a cryoprobe (Bruker, Billerica, MA,
United States). The samples were prepared using 50µM of
the 15N-labeled lectin in the corresponding buffer in a 90:10
H2O:D2O ratio. The experiments were performed at 298K. Six
to nine points were recorded for each ligand and CSP and KD
were calculated using CcpNmr Analysis 2.4.2.
Transverse ROESY Spectra
The NMR experiments were acquired using an 800 MHz
Bruker spectrometer with a cryoprobe (Bruker, Billerica, MA,
United States). The ROESY spectra for the glycans were acquired
in the presence of 50µMGal-4N with a 1:20 protein:ligand ratio
in the corresponding deuterated PBS buffer at 298 K.
Isothermal Titration Calorimetry
Isothermal titration calorimetry experiments were performed
using theMicroCal PEAQ-ITC calorimeter (Malvern Panalytical,
Malvern, United Kingdom). Samples containing 100–200µM
of Gal-4N in PBS (50mM sodium phosphate, pH 7.4, 300mM
NaCl) were titrated with stocks of 3–10mM in PBS of glycans 4, 5,
7, 8, 9, and 11. During the automated experiment, small aliquots
(2–3µL) of the sugar stocks were added to the cell containing the
lectin. Curve fitting to a single binding site model was performed
with the MicroCal Origin 7 software.
Molecular Dynamics Simulations
Initial complexes were built by pair-fitting the atomic coordinates
of the central βGal moiety of each studied ligand to those of the
βGal unit of the bound lactose in the ctystallographic structure
(pdb 5DUV). The glycan structures were built in the GLYCAM-
Web software. The MD simulations were run using Amber18
with the ff14SB force field for the protein and GLYCAM06j-1
for the carbohydrates. The complexes were prepared in explicit
water (TIP3PBOX) and minimized in two steps before starting
the simulations. The MD simulations of 1 µs were analyzed
using cpptraj.
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